🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with glp-1 and peripheral arterial disease? Page 2

Has anyone dealt with glp-1 and peripheral arterial disease?

traveltech_sara Fri, Jan 31, 2025 at 6:48 PM 24 replies 2,011 viewsPage 2 of 5
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Jan 31, 2025 at 10:13 PM#6
Dr.SleepRoch said:
Positive "side effect" of cardiovascular risk: my blood pressure dropped so much that I'm now off losartan entirely!

I read this differently from Dr.SleepRoch, on substance rather than tone. The "earlier than weight loss explains" argument is weaker than this thread makes it sound. Blood pressure and inflammatory markers move fast and are downstream of early weight loss, so the mechanism is not as cleanly separable as the summaries imply.

Correct me if the detail matters more than I have assumed.

Last edited: Feb 1, 2025 at 12:13 AM
26 4JakeSmashed95, NauseaFreeNow, SteveThurs and 23 others
Reply Quote Save Share Report
BiostatsBrad
Member
456
2,345
Jul 2024
Durham, NC
Jan 31, 2025 at 11:33 PM#7
traveltech_sara said:
My reason for being on this is cardiovascular rather than cosmetic, which puts me in a small minority in most of these threads.

6 month update on cardiovascular risk: down 52 lbs, off blood pressure meds, A1C normalized. Genuinely life-changing.

27 5Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 24 others
Reply Quote Save Share Report
Dr.EM_Chicago
Member
567
2,567
May 2024
Chicago, IL
Feb 1, 2025 at 12:53 AM#8
Dr.NateNeph said:
The "earlier than weight loss explains" argument is weaker than this thread makes it sound.
Dr.NateNeph said:
...we don't know the long-term effects of cardiovascular risk...

This is a fair point, and I think intellectual honesty requires acknowledging it. GLP-1 agonists in their current form have ~8-10 years of human exposure data. That's not nothing, but it's not 30+ years either.

However: the risk-benefit calculation should also consider the KNOWN long-term effects of untreated obesity — diabetes, cardiovascular disease, cancer, joint destruction, reduced lifespan by 5-10 years.

Uncertainty about GLP-1 long-term safety vs certainty about obesity consequences. The calculus seems clear to me, but reasonable people can disagree.

28 6Dr.ReproEndo, lucas_SP_BR, lisa_labSD and 25 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
jim_asheville
Member
289
1,234
Aug 2024
Asheville, NC
Feb 1, 2025 at 2:13 AM#9

One thing that is still open after bri_stats’s answer:

Did your prescriber agree with that reading, and if not what was their objection?

Last edited: Feb 1, 2025 at 5:13 AM
29 7wanda_boise, NurseAsh_DET, BenResearch_OR and 26 others
Reply Quote Save Share Report
traveltech_sara
Member
156
678
Jan 2025
Remote, USA
Feb 1, 2025 at 8:36 AM#10
Dr.EM_Chicago said:
Dr.NateNeph said: ...we don't know the long-term effects of cardiovascular risk...

Dizziness and cardiovascular risk: I was lightheaded for the first 3 weeks. Root cause was a combination of reduced caloric intake and mild dehydration.

Fix: minimum 80-100oz water daily, don't skip meals even if you're not hungry (eat small protein-rich snacks), and stand up slowly from sitting/lying positions. Also check your blood pressure — GLP-1-induced weight loss can make BP meds too strong, requiring dose reduction.

39 12BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 36 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register